143 related articles for article (PubMed ID: 32129443)
1. Usefulness of carbon-11-labeled methionine positron-emission tomography for assessing the treatment response of primary central nervous system lymphoma.
Miyakita Y; Ohno M; Takahashi M; Kurihara H; Katai H; Narita Y
Jpn J Clin Oncol; 2020 May; 50(5):512-518. PubMed ID: 32129443
[TBL] [Abstract][Full Text] [Related]
2.
Zhou W; Wen J; Hua F; Xu W; Lu X; Yin B; Geng D; Guan Y
Eur J Radiol; 2018 Jul; 104():26-32. PubMed ID: 29857862
[TBL] [Abstract][Full Text] [Related]
3. Use of PET in the diagnosis of primary CNS lymphoma in patients with atypical MR findings.
Kawai N; Okubo S; Miyake K; Maeda Y; Yamamoto Y; Nishiyama Y; Tamiya T
Ann Nucl Med; 2010 Jun; 24(5):335-43. PubMed ID: 20379859
[TBL] [Abstract][Full Text] [Related]
4. Prognostic Significance of Interim 11C-Methionine PET/CT in Primary Central Nervous System Lymphoma.
Ahn SY; Kwon SY; Jung SH; Ahn JS; Yoo SW; Min JJ; Bom HS; Ki SY; Kim HJ; Lee JJ; Song SY; Yang DH
Clin Nucl Med; 2018 Aug; 43(8):e259-e264. PubMed ID: 29877882
[TBL] [Abstract][Full Text] [Related]
5. [Usefulness and limitation of FDG-PET in the diagnosis of primary central nervous system lymphoma].
Kawai N; Miyake K; Okada M; Yamamoto Y; Nishiyama Y; Tamiya T
No Shinkei Geka; 2013 Feb; 41(2):117-26. PubMed ID: 23378387
[TBL] [Abstract][Full Text] [Related]
6. Delineation of brain tumor extent with [11C]L-methionine positron emission tomography: local comparison with stereotactic histopathology.
Kracht LW; Miletic H; Busch S; Jacobs AH; Voges J; Hoevels M; Klein JC; Herholz K; Heiss WD
Clin Cancer Res; 2004 Nov; 10(21):7163-70. PubMed ID: 15534088
[TBL] [Abstract][Full Text] [Related]
7. Comparison of 11C-methionine PET and 18F-FDG PET in patients with primary central nervous system lymphoma.
Kawase Y; Yamamoto Y; Kameyama R; Kawai N; Kudomi N; Nishiyama Y
Mol Imaging Biol; 2011 Dec; 13(6):1284-9. PubMed ID: 21042866
[TBL] [Abstract][Full Text] [Related]
8. Prospective study of
Yomo S; Oguchi K
BMC Cancer; 2017 Nov; 17(1):713. PubMed ID: 29110648
[TBL] [Abstract][Full Text] [Related]
9. Characteristics of time-activity curves obtained from dynamic
Nomura Y; Asano Y; Shinoda J; Yano H; Ikegame Y; Kawasaki T; Nakayama N; Maruyama T; Muragaki Y; Iwama T
J Neurooncol; 2018 Jul; 138(3):649-658. PubMed ID: 29564749
[TBL] [Abstract][Full Text] [Related]
10. (11)C-methionine PET/CT and MRI of primary central nervous system diffuse large B-cell lymphoma before and after high-dose methotrexate.
Jang SJ; Lee KH; Lee JY; Choi JY; Kim BT; Kim SJ; Kim WS
Clin Nucl Med; 2012 Oct; 37(10):e241-4. PubMed ID: 22955084
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic value of using 18F-FDG PET and PET/CT in immunocompetent patients with primary central nervous system lymphoma: A systematic review and meta-analysis.
Zou Y; Tong J; Leng H; Jiang J; Pan M; Chen Z
Oncotarget; 2017 Jun; 8(25):41518-41528. PubMed ID: 28514747
[TBL] [Abstract][Full Text] [Related]
12. A surgical strategy using a fusion image constructed from 11C-methionine PET, 18F-FDG-PET and MRI for glioma with no or minimum contrast enhancement.
Ideguchi M; Nishizaki T; Ikeda N; Okamura T; Tanaka Y; Fujii N; Ohno M; Shimabukuro T; Kimura T; Ikeda E; Suga K
J Neurooncol; 2018 Jul; 138(3):537-548. PubMed ID: 29516344
[TBL] [Abstract][Full Text] [Related]
13. Imaging features (CT, MRI, MRS, and PET/CT) of primary central nervous system lymphoma in immunocompetent patients.
Cheng G; Zhang J
Neurol Sci; 2019 Mar; 40(3):535-542. PubMed ID: 30580380
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic accuracy of 11C-methionine PET for differentiation of recurrent brain tumors from radiation necrosis after radiotherapy.
Terakawa Y; Tsuyuguchi N; Iwai Y; Yamanaka K; Higashiyama S; Takami T; Ohata K
J Nucl Med; 2008 May; 49(5):694-9. PubMed ID: 18413375
[TBL] [Abstract][Full Text] [Related]
15. A False-Negative Case of Primary Central Nervous System Lymphoma on 11C-Methionine PET and Intense 18F-FDG Uptake.
García-Garzon JR; Villasboas-Rosciolesi D; Baquero M; Bassa P; Soler M; Riera E
Clin Nucl Med; 2016 Aug; 41(8):664-5. PubMed ID: 27187734
[TBL] [Abstract][Full Text] [Related]
16. Optimization of semi-quantification in metabolic PET studies with 18F-fluorodeoxyglucose and 11C-methionine in the determination of malignancy of gliomas.
Borbély K; Nyáry I; Tóth M; Ericson K; Gulyás B
J Neurol Sci; 2006 Jul; 246(1-2):85-94. PubMed ID: 16603193
[TBL] [Abstract][Full Text] [Related]
17. The Application of Magnetic Resonance Imaging-Deformed 11C-Methionine-Positron Emission Tomography Images in Stereotactic Radiosurgery.
Jung TY; Jung S; Ryu HS; Kim IY; Jang WY; Moon KS; Lim SH; Kim DY; Kang SR; Min JJ; Bom HS; Kim SK; Kwon SY
Stereotact Funct Neurosurg; 2019; 97(4):217-224. PubMed ID: 31694035
[TBL] [Abstract][Full Text] [Related]
18. Clinical usefulness of coregistered 11C-methionine positron emission tomography/3-T magnetic resonance imaging at the follow-up of acromegaly.
Rodriguez-Barcelo S; Gutierrez-Cardo A; Dominguez-Paez M; Medina-Imbroda J; Romero-Moreno L; Arraez-Sanchez M
World Neurosurg; 2014; 82(3-4):468-73. PubMed ID: 24239736
[TBL] [Abstract][Full Text] [Related]
19. What is the Best Preoperative Quantitative Indicator to Differentiate Primary Central Nervous System Lymphoma from Glioblastoma?
Inoue A; Matsumoto S; Ohnishi T; Miyazaki Y; Kinnami S; Kanno K; Honda T; Kurata M; Taniwaki M; Kusakabe K; Suehiro S; Yamashita D; Shigekawa S; Watanabe H; Kitazawa R; Kunieda T
World Neurosurg; 2023 Apr; 172():e517-e523. PubMed ID: 36690204
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathological characteristics of primary central nervous system lymphoma with low 18F-fludeoxyglucose uptake on brain positron emission tomography.
Kim HO; Kim JS; Kim SO; Chae SY; Oh SJ; Seo M; Lee SH; Oh JS; Ryu JS; Huh JR; Kim JH
Medicine (Baltimore); 2020 May; 99(20):e20140. PubMed ID: 32443328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]